{"pmid":32238000,"title":"Teledermatology: a useful tool to fight COVID-19.","text":["Teledermatology: a useful tool to fight COVID-19.","J Dermatolog Treat","Villani, Alessia","Scalvenzi, Massimiliano","Fabbrocini, Gabriella","32238000"],"journal":"J Dermatolog Treat","authors":["Villani, Alessia","Scalvenzi, Massimiliano","Fabbrocini, Gabriella"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238000","week":"202014|Mar 30 - Apr 05","doi":"10.1080/09546634.2020.1750557","keywords":["COVID-19","coronavirus","dermatology","prevention","teledermatology","telemedicine"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662996001762312193,"score":7.6048946,"similar":[{"pmid":32243612,"title":"WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side.","text":["WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side.","The current coronavirus disease (COVID-19) has forced the shutdown of many non-essential services in most of the high-risk countries. Most of the consultations (except emergencies) in dermatology are deferred as a precautionary measure to prevent the spread of COVID-19.","Clin Exp Dermatol","Deepak, J","Subuhi, K","Ishmeet, K","32243612"],"abstract":["The current coronavirus disease (COVID-19) has forced the shutdown of many non-essential services in most of the high-risk countries. Most of the consultations (except emergencies) in dermatology are deferred as a precautionary measure to prevent the spread of COVID-19."],"journal":"Clin Exp Dermatol","authors":["Deepak, J","Subuhi, K","Ishmeet, K"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243612","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ced.14227","keywords":["COVID-19","coronavirus","social distancing","teledermatology","telemedicine","whatsapp"],"source":"PubMed","locations":["Bedside"],"topics":["Prevention"],"weight":1,"_version_":1663079112821964800,"score":162.10098},{"pmid":32238336,"title":"Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","text":["Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine.","JMIR Public Health Surveill","Ohannessian, Robin","Duong, Tu Anh","Odone, Anna","32238336"],"abstract":["On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine."],"journal":"JMIR Public Health Surveill","authors":["Ohannessian, Robin","Duong, Tu Anh","Odone, Anna"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238336","week":"202014|Mar 30 - Apr 05","doi":"10.2196/18810","keywords":["COVID-19","SARS-CoV-2","coronavirus","digital health","digital medicine","outbreak","pandemic","public health","surveillance","telehealth","telemedicine"],"source":"PubMed","locations":["United Kingdom","France","Italy"],"countries":["Italy","United Kingdom","France"],"countries_codes":["ITA|Italy","GBR|United Kingdom","FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1662996001801109505,"score":68.49977},{"pmid":32213307,"title":"Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatolgy visits.","text":["Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatolgy visits.","J Am Acad Dermatol","Kwatra, Shawn G","Sweren, Ronald J","Grossberg, Anna L","32213307"],"journal":"J Am Acad Dermatol","authors":["Kwatra, Shawn G","Sweren, Ronald J","Grossberg, Anna L"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32213307","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.jaad.2020.03.037","keywords":["COVID-19","coronavirus","dermatology"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662445896480063489,"score":65.06163},{"pmid":32201972,"title":"Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital.","text":["Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital.","On December 31, 2019, from the Chinese city of Wuhan, Hubei, comes the first case of \"atypcal ARDS/ interstitial pneumonia\". On February 11, 2020 the WHO officially announced the new name of the pathology associated with the coronavirus: COVID-19 (Coronavirus Disease 2019). On February 13, 72000 cases have been recorded in China, of which 15000 in Hubei with 242 deaths in a single day. For this reason China put in place drastic containment measures for the virus spreading.","J Eur Acad Dermatol Venereol","Radi, G","Diotallevi, F","Campanati, A","Offidani, A","32201972"],"abstract":["On December 31, 2019, from the Chinese city of Wuhan, Hubei, comes the first case of \"atypcal ARDS/ interstitial pneumonia\". On February 11, 2020 the WHO officially announced the new name of the pathology associated with the coronavirus: COVID-19 (Coronavirus Disease 2019). On February 13, 72000 cases have been recorded in China, of which 15000 in Hubei with 242 deaths in a single day. For this reason China put in place drastic containment measures for the virus spreading."],"journal":"J Eur Acad Dermatol Venereol","authors":["Radi, G","Diotallevi, F","Campanati, A","Offidani, A"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32201972","week":"202013|Mar 23 - Mar 29","doi":"10.1111/jdv.16386","keywords":["COVID-19","dermatology","pandemic"],"source":"PubMed","locations":["China","Chinese","Wuhan","Hubei","Italian"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1662334543304065024,"score":55.554825},{"pmid":32223068,"title":"Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19).","text":["Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19).","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in December 2019 in Wuhan, China has spread to over 113 countries with 118,326 infected and 4,292 died as of 11 March 2020 and the World Health Organization (WHO) has just announced COVID-19 a global pandemic. A person under investigation (PUI) for COVID-19 is less likely to present initially to the ophthalmologists compared to emergency care or internal medicine physicians. However, in late February 2020, 2 patients presented simultaneously to our eye casualty with sudden onset of unilateral painful red eye associated with a decline in visual acuity, their intraocular pressure (IOP) were over 40 mmHg and slit-lamp examination findings were suggestive of acute primary angle closure (APAC).","Acta Ophthalmol","Wan, Kelvin H","Huang, Suber S","Young, Alvin","Chiu Lam, Dennis Shun","32223068"],"abstract":["The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in December 2019 in Wuhan, China has spread to over 113 countries with 118,326 infected and 4,292 died as of 11 March 2020 and the World Health Organization (WHO) has just announced COVID-19 a global pandemic. A person under investigation (PUI) for COVID-19 is less likely to present initially to the ophthalmologists compared to emergency care or internal medicine physicians. However, in late February 2020, 2 patients presented simultaneously to our eye casualty with sudden onset of unilateral painful red eye associated with a decline in visual acuity, their intraocular pressure (IOP) were over 40 mmHg and slit-lamp examination findings were suggestive of acute primary angle closure (APAC)."],"journal":"Acta Ophthalmol","authors":["Wan, Kelvin H","Huang, Suber S","Young, Alvin","Chiu Lam, Dennis Shun"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32223068","week":"202014|Mar 30 - Apr 05","doi":"10.1111/aos.14438","keywords":["COVID-19","SARS-CoV-2","eye","ophthalmologists","precautionary measures","prevention"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis"],"weight":1,"_version_":1663095625700343808,"score":52.288475}]}